Videos

Drone Use Plausible for Cardiac Arrest Emergencies

Drone Use Plausible for Cardiac Arrest Emergencies

New research suggests that drones can be used to quickly deliver defibrillators in sudden cardiac arrest emergencies.

Higher Systolic Blood Pressure in Racially Segregated Areas

Higher Systolic Blood Pressure in Racially Segregated Areas

An increase in systolic blood pressure was found in individuals living in racial segregated neighborhoods.

Best of the 2017 American College of Cardiology Scientific Session & Expo

Best of the 2017 American College of Cardiology Scientific Session & Expo

Highlights from the 2017 American College of Cardiology Scientific Session & Expo.

VIDEO: Oral Anticoagulation After Intracranial Hemorrhage in Afib

VIDEO: Oral Anticoagulation After Intracranial Hemorrhage in Afib

Restarting oral anticoagulation in patients with atrial fibrillation after an intracranial hemorrhage may improve outcomes.

VIDEO: CMR Imaging in Suspected CHD

VIDEO: CMR Imaging in Suspected CHD

Both cardiovascular magnetic resonance imaging and myocardial perfusion scintigraphy strategies reduced unncessary angiography rates compared with NICE guidelines.

VIDEO: Alirocumab Reduced Use of Apheresis

VIDEO: Alirocumab Reduced Use of Apheresis

Overall, 92.7% of patients assigned to alirocumab were able to cut their use of lipoprotein apheresis by at least half.

VIDEO: Diabetes and Obesity in Walkable Neighborhoods

VIDEO: Diabetes and Obesity in Walkable Neighborhoods

A "walkability index" was assigned to each neighborhood.

Familial Hypercholesterolemia: Are PCSK9 Inhibitors Cost-Effective?

Familial Hypercholesterolemia: Are PCSK9 Inhibitors Cost-Effective?

PCSK9 inhibitors are highly effective in patients with familial hypercholesterolemia who cannot tolerate statins, but that effectiveness is costly.

VIDEO: Major Bleeding in Patients with Atrial Fibrillation and Diabetes Taking Rivaroxaban

VIDEO: Major Bleeding in Patients with Atrial Fibrillation and Diabetes Taking Rivaroxaban

W. Frank Peacock, IV, MD, discusses the risk of major bleeding among patients with atrial fibrillation and diabetes who are receiving rivaroxaban.

Sign Up for Free e-Newsletters